Unlocking Answers to Your Health

Sema4 is a health information company dedicated to improving the diagnosis, treatment, and prevention of disease through deep data analysis

Our Story

Trust in Sema4

  • Our Story

    Backed by the reputation of Mount Sinai and groundbreaking research from the Icahn School of Medicine Learn More
  • Our Technology

    Six genomic technologies used in parallel to ensure comprehensive and highly accurate screening for genetic conditions Learn More
  • Our Products

    Genetic tests to empower patients and their doctors to make better health decisions, now and in the future Learn More
  • Our Research

    Breakthrough discoveries from our scientists in the fields of genetics and genomics Learn More


    SEMA4 PRESS RELEASE | 02.07.18

    Sema4 Launches Supplemental Newborn Screening Test for 190+ Childhood-Onset Diseases

    “Sema4 today announced the launch of Sema4 Natalis, a supplemental newborn screening test designed to detect 193 childhood-onset diseases or disorders so parents can gain early insight into their baby’s health. This simple genetic test can be performed at home with a gentle cheek swab…”